Appointed – Erik van den Berg as Chair of Board

TargED is pleased to announce the appointment of Erik van den Berg as Chair of its Supervisory Board.

Kristof Vercruysse, CEO of TargED commented: “We are honored to have Erik van den Berg join as independent Chair of the TargED Board. With his extensive experience and outstanding track record in biotechnology business development we are convinced that Erik will be a valuable contributor for TargED as we continue to develop our main compound Microlyse to better the treatment of Thrombosis”.